Related Experiment Video
Updated: May 28, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Molecular pathogenesis of cholangiocarcinoma
1Division of Gastroenterology, Azienda Ospedaliero-Universitaria "Ospedali Riuniti" Via Conca 72, 60020 Ancona, Italy.
Cholangiocarcinoma (CC) incidence is rising globally. This study details recent scientific progress in understanding the molecular pathways driving CC development and progression, crucial for new treatments.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Cholangiocarcinoma (CC) incidence and mortality show a concerning global increase.
- The complex pathophysiology of CC remains incompletely understood.
- Existing knowledge highlights chronic inflammation as a key factor in cholangiocarcinogenesis.
Purpose of the Study:
- To review recent scientific advancements in defining molecular mechanisms of CC.
- To elucidate the multistep process of cholangiocarcinogenesis from normal biliary cells to malignancy.
- To identify molecular pathways critical for CC growth and progression.
Main Methods:
- Review of recent epidemiological data on CC incidence and mortality.
- Analysis of scientific literature on molecular mechanisms of cholangiocyte transformation.
- Synthesis of current understanding of the multistep process of cholangiocarcinogenesis.
Main Results:
- Significant progress has been made in identifying molecular pathways involved in CC.
- Cholangiocarcinogenesis is increasingly recognized as a multistep process initiated by chronic inflammation.
- Understanding these molecular drivers is essential for improving CC prognosis.
Conclusions:
- Further research into CC molecular pathways is vital for developing effective treatments.
- Identifying key molecular mechanisms will aid in creating preventive strategies for cholangiocarcinoma.
- This review consolidates recent findings on the molecular basis of this devastating biliary cancer.
More Related Videos
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cirrhosis II: Pathophysiology
Mutagenicity and Carcinogenicity
Cancers Originate from Somatic Mutations in a Single Cell
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...